![Frederick W. Kyle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frederick W. Kyle
Vorsitzender bei BioRexis Pharmaceutical Corp.
Aktive Positionen von Frederick W. Kyle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BioRexis Pharmaceutical Corp.
![]() BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Vorsitzender | - | - |
Suvoda LLC
![]() Suvoda LLC Packaged SoftwareTechnology Services Suvoda LLC provides software solutions for clinical supply chain management. It specializes in interactive response technology, subject randomization, trial supply management, interactive web response system, patient logistics, and clinical supply logistics. The company was founded by Jagath Wanninayake, Robert Hummel, Marius Manole, Marc Lisi, and Adrian Vasile in 2012 and is headquartered in Conshohocken, PA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Frederick W. Kyle
Ehemalige bekannte Positionen von Frederick W. Kyle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Smithkline Beecham Plc
![]() Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Geschäftsführer | - | - |
AVANT Immunotherapeutics, Inc.
![]() AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 2 |
Chairman | 1 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 4 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
AVANT Immunotherapeutics, Inc.
![]() AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Health Technology |
BioRexis Pharmaceutical Corp.
![]() BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Smithkline Beecham Plc
![]() Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Suvoda LLC
![]() Suvoda LLC Packaged SoftwareTechnology Services Suvoda LLC provides software solutions for clinical supply chain management. It specializes in interactive response technology, subject randomization, trial supply management, interactive web response system, patient logistics, and clinical supply logistics. The company was founded by Jagath Wanninayake, Robert Hummel, Marius Manole, Marc Lisi, and Adrian Vasile in 2012 and is headquartered in Conshohocken, PA. | Technology Services |
- Börse
- Insiders
- Frederick W. Kyle
- Erfahrung